Nuclear phospholipase C in biological control and cancer

Critical Reviews in Eukaryotic Gene Expression

Volumn 21, Issue 3, 2011, Pages 291-301

  Ramazzotti, Giulia ^a   Faenza, Irene ^a   Follo, Matilde Y ^a   Fiume, Roberta ^a   Piazzi, Manuela ^a   Giardino, Roberto ^b   Fini, Milena ^b   Cocco, Lucio ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b RIZZOLI ORTHOPAEDIC INSTITUTE   (Italy)

Author keywords

Inositides; Myelodysplastic syndromes; Nucleus; Phospholipase C

Indexed keywords

AZACITIDINE; INOSITOL PHOSPHATE; PHOSPHOLIPASE C BETA1; PHOSPHOLIPASE C DELTA; PHOSPHOLIPASE C GAMMA1;

ACUTE GRANULOCYTIC LEUKEMIA; APOPTOSIS; ARTICLE; CANCER CELL; CANCER GROWTH; CANCER RESISTANCE; CELL GROWTH; CELL PROLIFERATION; DISEASE COURSE; HUMAN; MULTIPLE CYCLE TREATMENT; MYELODYSPLASTIC SYNDROME; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL;

EID: 81355154524     PISSN: 10454403     EISSN: None     Source Type: Journal    
DOI: 10.1615/CritRevEukarGeneExpr.v21.i3.50     Document Type: Article

References (77)

1. Faenza I, Bregoli L, Ramazzotti G, Gaboardi G, Faen-za I, Bregoli L, Ramazzotti G, Gaboardi G, Follo MY, Mongiorgi S, Billi AM, Manzoli L, Martelli AM, Cocco L. Nuclear phospholipase C beta1 and cellular differentiation. Front Biosci. 2008;13:2452-63.
2. Zhao K, Wang W, Rando OJ, Xue Y, Swiderek K, Kuo A, Crabtree GR. Rapid and phosphoinositol-dependent binding of the SWI/SNF-like BAF complex to chromatin after T lymphocyte receptor signaling. Cell. 1998 Nov 25;95(5):625-36.
3. Yu H, Fukami K, Watanabe Y, Ozaki C, Takenawa T. Phosphatidylinositol 4,5-bisphosphate reverses the inhibition of RNA transcription caused by histone H1. Eur J Biochem. 1998 Jan 15;251(1-2):281-7.
4. Cocco L, Faenza I, Follo MY, Billi AM, Ramazzotti G, Papa V, Martelli AM, Manzoli L. Nuclear inositides: PI-PLC signaling in cell growth, differentiation and pathology. Adv Enzyme Regul. 2009;49(1):2-10.
5. Martelli AM, Gilmour RS, Bertagnolo V, Neri LM, Manzoli L, Cocco L. Nuclear localization and signalling activity of phosphoinositidase C beta in Swiss 3T3 cells. Nature. 1992 Jul 16;358(6383):242-5.
6. Wymann MP, Schneiter R. Lipid signalling in disease. Nat Rev Mol Cell Biol. 2008 Feb;9(2):162-76.
7. Bahk YY, Song H, Baek SH, Park BY, Kim H, Ryu SH, Suh PG. Localization of two forms of phospholipase C-beta1, a and b, in C6Bu-1 cells. Biochim Biophys Acta. 1998 Jan 5;1389(1):76-80.
8. Peruzzi D, Aluigi M, Manzoli L, Billi AM, Di Giorgio FP, Morleo M, Martelli AM, Cocco L. Molecular characterization of the human PLC beta1 gene. Biochim Biophys Acta. 2002 Sep 5;1584(1):46-54.
9. Suh PG, Park JI, Manzoli L, Cocco L, Peak JC, Katan M, Fukami K, Kataoka T, Yun S, Ryu SH. Multiple roles of phosphoinositide-specific phospholipase C isozymes. BMB Rep. 2008 Jun 30;41(6):415-34.
10. Payrastre B, Nievers M, Boonstra J, Breton M, Verkleij AJ, Van Bergen en Henegouwen PM. A differential location of phosphoinositide kinases, diacylglycerol kinase, and phospholipase C in the nuclear matrix. J Biol Chem. 1992 Mar 15;267(8):5078-84.
11. Deleris P, Bacqueville D, Gayral S, Carrez L, Salles JP, Perret B, Breton-Douillon M. SHIP-2 and PTEN are expressed and active in vascular smooth muscle cell nuclei, but only SHIP-2 is associated with nuclear speckles. J Biol Chem. 2003 Oct 3;278(40):38884-91.
12. Didichenko SA, Thelen M. Phosphatidylinositol 3-kinase c2alpha contains a nuclear localization sequence and associates with nuclear speckles. J Biol Chem. 2001 Dec 21;276(51):48135-42.
13. Tabellini G, Bortul R, Santi S, Riccio M, Baldini G, Cappellini A, Billi AM, Berezney R, Ruggeri A, Cocco L, Martelli AM. Diacylglycerol kinase-theta is localized in the speckle domains of the nucleus. Exp Cell Res. 2003 Jul 1;287(1):143-54.
14. Aisiku O, Dowal L, Scarlata S. Protein kinase C phosphorylation of PLCbeta1 regulates its cellular localization. Arch Biochem Biophys. May 15;509(2):186-90.
15. Choi JH, Park JB, Bae SS, Yun S, Kim HS, Hong WP, Kim IS, Kim JH, Han MY, Ryu SH, Patterson RL, Snyder SH, Suh PG. Phospholipase C-gamma1 is a guanine nucleotide exchange factor for dynamin-1 and enhances dynamin-1-dependent epidermal growth factor receptor endocytosis. J Cell Sci. 2004 Aug 1;117(Pt 17):3785-95.
16. Ye K, Aghdasi B, Luo HR, Moriarity JL, Wu FY, Hong JJ, Hurt KJ, Bae SS, Suh PG, Snyder SH. Phospholipase C gamma 1 is a physiological guanine nucleotide exchange factor for the nuclear GTPase PIKE. Nature. 2002 Jan 31;415(6871):541-4.
17. Ye K. PIKE/nuclear PI 3-kinase signaling in preventing programmed cell death. J Cell Biochem. 2005 Oct 15;96(3):463-72.
18. Ye K, Snyder SH. PIKE GTPase: a novel mediator of phosphoinositide signaling. J Cell Sci. 2004 Jan 15;117(Pt 2):155-61.
19. Stallings JD, Tall EG, Pentyala S, Rebecchi MJ. Nuclear translocation of phospholipase C-delta1 is linked to the cell cycle and nuclear phosphatidylinositol 4,5-bisphosphate. J Biol Chem. 2005 Jun 10;280(23):22060-9.
20. Yamaga M, Fujii M, Kamata H, Hirata H, Yagisawa H. Phospholipase C-delta1 contains a functional nuclear export signal sequence. J Biol Chem. 1999 Oct 1;274(40):28537-41.
21. Stallings JD, Zeng YX, Narvaez F, Rebecchi MJ. Phospholipase C-delta1 expression is linked to proliferation, DNA synthesis, and cyclin E levels. J Biol Chem. 2008 May 16;283(20):13992-4001.
22. Saunders CM, Larman MG, Parrington J, Cox LJ, Royse J, Blayney LM, Swann K, Lai FA. PLC zeta: a sperm-specific trigger of Ca(2+) oscillations in eggs and embryo development. Development. 2002 Aug;129(15):3533-44.
23. Yoda A, Oda S, Shikano T, Kouchi Z, Awaji T, Shirakawa H, Kinoshita K, Miyazaki S. Ca2+ oscillation-inducing phospholipase C zeta expressed in mouse eggs is accumulated to the pronucleus during egg activation. Dev Biol. 2004 Apr 15;268(2):245-57.
24. Larman MG, Saunders CM, Carroll J, Lai FA, Swann K. Cell cycle-dependent Ca2+ oscillations in mouse embryos are regulated by nuclear targeting of PLCzeta. J Cell Sci. 2004 May 15;117(Pt 12):2513-21.
25. Swann K, Saunders CM, Rogers NT, Lai FA. PLCzeta(zeta): a sperm protein that triggers Ca2+ oscillations and egg activation in mammals. Semin Cell Dev Biol. 2006 Apr;17(2):264-73.
26. Cocco L, Martelli AM, Gilmour RS, Ognibene A, Manzoli FA, Irvine RF. Changes in nuclear inositol phospholipids induced in intact cells by insulin-like growth factor I. Biochem Biophys Res Commun. 1989 Mar 15;159(2):720-5.
27. Divecha N, Banfic H, Irvine RF. The polyphosphoinositide cycle exists in the nuclei of Swiss 3T3 cells under the control of a receptor (for IGF-I) in the plasma membrane, and stimulation of the cycle increases nuclear diacylglycerol and apparently induces translocation of protein kinase C to the nucleus. Embo J. 1991 Nov;10(11):3207-14.
28. Manzoli L, Billi AM, Rubbini S, Bavelloni A, Faenza I, Gilmour RS, Rhee SG, Cocco L. Essential role for nuclear phospholipase C beta1 in insulin-like growth factor I-induced mitogenesis. Cancer Res. 1997 Jun 1;57(11):2137-9.
29. Divecha N, Rhee SG, Letcher AJ, Irvine RF. Phosphoinositide signalling enzymes in rat liver nuclei: phosphoinositidase C isoform beta 1 is specifically, but not predominantly, located in the nucleus. Biochem J. 1993 Feb 1;289 (Pt 3):617-20.
30. Xu A, Suh PG, Marmy-Conus N, Pearson RB, Seok OY, Cocco L, Gilmour RS. Phosphorylation of nuclear phospholipase C beta1 by extracellular signal-regulated kinase mediates the mitogenic action of insulin-like growth factor I. Mol Cell Biol. 2001 May;21(9):2981-90.
31. Kumar V, Jong YJ, O'Malley KL. Activated nuclear metabotropic glutamate receptor mGlu5 couples to nuclear Gq/11 proteins to generate inositol 1,4,5-trisphosphate-mediated nuclear Ca2+ release. J Biol Chem. 2008 May 16;283(20):14072-83.
32. Lukinovic-Skudar V, Donlagic L, Banfic H, Visnjic D. Nuclear phospholipase C-beta1b activation during G2/M and late G1 phase in nocodazole-synchronized HL-60 cells. Biochim Biophys Acta. 2005 Apr 15;1733(2-3):148-56.
33. Lukinovic-Skudar V, Matkovic K, Banfic H, Visnjic D. Two waves of the nuclear phospholipase C activity in serum-stimulated HL-60 cells during G(1) phase of the cell cycle. Biochim Biophys Acta. 2007 Apr;1771(4):514-21.
34. Visnjic D, Banfic H. Nuclear phospholipid signaling: phosphatidylinositol-specific phospholipase C and phosphoinositide 3-kinase. Pflugers Arch. 2007 Oct;455(1):19-30.
35. Goss VL, Hocevar BA, Thompson LJ, Stratton CA, Burns DJ, Fields AP. Identification of nuclear beta II protein kinase C as a mitotic lamin kinase. J Biol Chem. 1994 Jul 22;269(29):19074-80.
36. Hocevar BA, Burns DJ, Fields AP. Identification of protein kinase C (PKC) phosphorylation sites on human lamin B. Potential role of PKC in nuclear lamina structural dynamics. J Biol Chem. 1993 Apr 5;268(10):7545-52.
37. Hocevar BA, Fields AP. Selective translocation of beta II-protein kinase C to the nucleus of human promyelocytic (HL60) leukemia cells. J Biol Chem. 1991 Jan 5;266(1):28-33.
38. Gokmen-Polar Y, Fields AP. Mapping of a molecular determinant for protein kinase C betaII isozyme function. J Biol Chem. 1998 Aug 7;273(32):20261-6.
39. Sun B, Murray NR, Fields AP. A role for nuclear phosphatidylinositol-specific phospholipase C in the G2/M phase transition. J Biol Chem. 1997 Oct 17;272(42):26313-7.
40. Walker SD, Murray NR, Burns DJ, Fields AP. Protein kinase C chimeras: catalytic domains of alpha and beta II protein kinase C contain determinants for isotype-specific function. Proc Natl Acad Sci U S A. 1995 Sep 26;92(20):9156-60.
41. Fiume R, Ramazzotti G, Teti G, Chiarini F, Faenza I, Mazzotti G, Billi AM, Cocco L. Involvement of nuclear PLCbeta1 in lamin B1 phosphorylation and G2/M cell cycle progression. FASEB J. 2009 Mar;23(3):957-66.
42. Avazeri N, Courtot AM, Pesty A, Duquenne C, Lefevre B. Cytoplasmic and nuclear phospholipase C-beta 1 relocation: role in resumption of meiosis in the mouse oocyte. Mol Biol Cell. 2000 Dec;11(12):4369-80.
43. York JD, Majerus PW. Nuclear phosphatidylinositols decrease during S-phase of the cell cycle in HeLa cells. J Biol Chem. 1994 Mar 18;269(11):7847-50.
44. Faenza I, Matteucci A, Manzoli L, Billi AM, Aluigi M, Peruzzi D, Vitale M, Castorina S, Suh PG, Cocco L. A role for nuclear phospholipase Cbeta 1 in cell cycle control. J Biol Chem. 2000 Sep 29;275(39):30520-4.
45. Ho KK, Anderson AA, Rosivatz E, Lam EW, Woscholski R, Mann DJ. Identification of cyclin A2 as the downstream effector of the nuclear phosphatidylinositol 4,5-bisphosphate signaling network. J Biol Chem. 2008 Feb 29;283(9):5477-85.
46. Divecha N, Roefs M, Los A, Halstead J, Bannister A, D'Santos C. Type I PIPkinases interact with and are regulated by the retinoblastoma susceptibility gene product-pRB. Curr Biol. 2002 Apr 2;12(7):582-7.
47. Los AP, Vinke FP, de Widt J, Topham MK, van Blitterswijk WJ, Divecha N. The retinoblastoma family proteins bind to and activate diacylglycerol kinase zeta. J Biol Chem. 2006 Jan 13;281(2):858-66.
48. Evangelisti C, Tazzari PL, Riccio M, Fiume R, Hozumi Y, Falà F, Goto K, Manzoli L, Cocco L, Martelli AM. Nuclear diacylglycerol kinase-zeta is a negative regulator of cell cycle progression in C2C12 mouse myoblasts. FASEB J. 2007 Oct;21(12):3297-307.
49. Mellman DL, Anderson RA. A novel gene expression pathway regulated by nuclear phosphoinositides. Adv Enzyme Regul. 2009;49(1):11-28.
50. Cocco L, Gilmour RS, Ognibene A, Letcher AJ, Manzoli FA, Irvine RF. Synthesis of polyphosphoinositides in nuclei of Friend cells. Evidence for polyphosphoinositide metabolism inside the nucleus which changes with cell differentiation. Biochem J. 1987 Dec 15;248(3):765-70.
51. Manzoli FA, Martelli AM, Capitani S, Maraldi NM, Rizzoli R, Barnabei O, Cocco L. Nuclear polyphosphoinositides during cell growth and differentiation. Adv Enzyme Regul. 1989;28:25-34.
52. Divecha N, Letcher AJ, Banfic HH, Rhee SG, Irvine RF. Changes in the components of a nuclear inositide cycle during differentiation in murine erythroleukaemia cells. Biochem J. 1995 Nov 15;312 (Pt 1):63-7.
53. Hinchliffe KA, Irvine RF, Divecha N. Regulation of PtdIns4P 5-kinase C by thrombin-stimulated changes in its phosphorylation state in human platelets. Biochem J. 1998 Jan 1;329 (Pt 1):115-9.
54. Martelli AM, Billi AM, Gilmour RS, Neri LM, Manzoli L, Ognibene A, Cocco L. Phosphoinositide signaling in nuclei of Friend cells: phospholipase C beta down-regulation is related to cell differentiation. Cancer Res. 1994 May 15;54(10):2536-40.
55. Matteucci A, Faenza I, Gilmour RS, Manzoli L, Billi AM, Peruzzi D, Bavelloni A, Rhee SG, Cocco L. Nuclear but not cytoplasmic phospholipase C beta 1 inhibits differentiation of erythroleukemia cells. Cancer Res. 1998 Nov 15;58(22):5057-60.
56. Faenza I, Matteucci A, Bavelloni A, Marmiroli S, Martelli AM, Gilmour RS, Suh PG, Manzoli L, Cocco L. Nuclear PLCbeta(1) acts as a negative regulator of p45/NF-E2 expression levels in Friend erythroleukemia cells. Biochim Biophys Acta. 2002 May 8;1589(3):305-10.
57. Bavelloni A, Faenza I, Cioffi G, Piazzi M, Parisi D, Matic I, Maraldi NM, Cocco L. Proteomic-based analysis of nuclear signaling: PLCbeta1 affects the expression of the splicing factor SRp20 in Friend erythroleukemia cells. Proteomics. 2006 Nov;6(21):5725-34.
58. Fiume R, Faenza I, Matteucci A, Astolfi A, Vitale M, Martelli AM, Cocco L. Nuclear phospholipase C beta1 (PLCbeta1) affects CD24 expression in murine erythroleukemia cells. J Biol Chem. 2005 Jun 24;280(25):24221-6.
59. Faenza I, Bavelloni A, Fiume R, Lattanzi G, Maraldi NM, Gilmour RS, Martelli AM, Suh PG, Billi AM, Cocco L. Up-regulation of nuclear PLCbeta1 in myogenic differentiation. J Cell Physiol. 2003 Jun;195(3):446-52.
60. Ramazzotti G, Faenza I, Gaboardi GC, Piazzi M, Bavelloni A, Fiume R, Manzoli L, Martelli AM, Cocco L. Catalytic activity of nuclear PLC-beta(1) is required for its signalling function during C2C12 differentiation. Cell Signal. 2008 Jul 20.
61. Cenciarelli C, De Santa F, Puri PL, Mattei E, Ricci L, Bucci F, Felsani A, Caruso M. Critical role played by cyclin D3 in the MyoD-mediated arrest of cell cycle during myoblast differentiation. Mol Cell Biol. 1999 Jul;19(7):5203-17.
62. Faenza I, Billi AM, Follo MY, Fiume R, Martelli AM, Cocco L, Manzoli L. Nuclear phospholipase C signaling through type 1 IGF receptor and its involvement in cell growth and differentiation. Anticancer Res. 2005 May-Jun;25(3B):2039-41.
63. O'Carroll SJ, Mitchell MD, Faenza I, Cocco L, Gilmour RS. Nuclear PLCbeta1 is required for 3T3-L1 adipocyte differentiation and regulates expression of the cyclin D3-cdk4 complex. Cell Signal. 2009 Jun;21(6):926-35.
64. Evangelisti C, Riccio M, Faenza I, Zini N, Hozumi Y, Goto K, Cocco L, Martelli AM. Subnuclear localization and differentiation-dependent increased expression of DGK-zeta in C2C12 mouse myoblasts. J Cell Physiol. 2006 Nov;209(2):370-8.
65. Ross EM, Mateu D, Gomes AV, Arana C, Tran T, Litosch I. Structural determinants for phosphatidic acid regulation of phospholipase C-beta1. J Biol Chem. 2006 Nov 3;281(44):33087-94.
66. Scott BL, Deeg HJ. Myelodysplastic syndromes. Annu Rev Med. 2010;61:345-58.
67. Steensma DP, Tefferi A. The myelodysplastic syndrome(s): a perspective and review highlighting current controversies. Leuk Res. 2003 Feb;27(2):95-120.
68. Barzi A, Sekeres MA. Myelodysplastic syndromes: a practical approach to diagnosis and treatment. Cleve Clin J Med. 2010 Jan;77(1):37-44.
69. Fenaux P, Mufti GJ, Hellstrom-Lindberg E, Santini V, Finelli C, Giagounidis A, Schoch R, Gattermann N, Sanz G, List A, Gore SD, Seymour JF, Bennett JM, Byrd J, Backstrom J, Zimmerman L, McKenzie D, Beach C, Silverman LR; International Vidaza High-Risk MDS Survival Study Group. Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study. Lancet Oncol. 2009 Mar;10(3):223-32.
70. Muller-Thomas C, Schuster T, Peschel C, Gotze KS. A limited number of 5-azacitidine cycles can be effective treatment in MDS. Ann Hematol. 2009 Mar;88(3):213-9.
71. Daskalakis M, Nguyen TT, Nguyen C, Guldberg P, Kohler G, Wijermans P, Jones PA, Lübbert M. Demethylation of a hypermethylated P15/INK4B gene in patients with myelodysplastic syndrome by 5-Aza-2'-deoxycytidine (decitabine) treatment. Blood. 2002 Oct 15;100(8):2957-64.
72. Raj K, John A, Ho A, Chronis C, Khan S, Samuel J, Pomplun S, Thomas NS, Mufti GJ. CDKN2B methylation status and isolated chromosome 7 abnormalities predict responses to treatment with 5-azacytidine. Leukemia. 2007 Sep;21(9):1937-44.
73. Follo MY, Finelli C, Clissa C, Mongiorgi S, Bosi C, Martinelli G, Baccarani M, Manzoli L, Martelli AM, Cocco L. Phosphoinositide-phospholipase C beta1 mono-allelic deletion is associated with myelodysplastic syndromes evolution into acute myeloid leukemia. J Clin Oncol. 2009 Feb 10;27(5):782-90.
74. Follo MY, Bosi C, Finelli C, Fiume R, Faenza I, Ramazzotti G, Gaboardi GC, Manzoli L, Cocco L. Real-time PCR as a tool for quantitative analysis of PI-PLCbeta1 gene expression in myelodysplastic syndrome. Int J Mol Med. 2006 Aug;18(2):267-71.
75. Follo MY, Finelli C, Bosi C, Martinelli G, Mongiorgi S, Baccarani M, Manzoli L, Blalock WL, Martelli AM, Cocco L. PI-PLCbeta-1 and activated Akt levels are linked to azacitidine responsiveness in high-risk myelodysplastic syndromes. Leukemia. 2008 Jan;22(1):198-200.
76. Follo MY, Finelli C, Mongiorgi S, Clissa C, Bosi C, Testoni N, Chiarini F, Ramazzotti G, Baccarani M, Martelli AM, Manzoli L, Martinelli G, Cocco L. Reduction of phosphoinositide-phospholipase C beta1 methylation predicts the responsiveness to azacitidine in high-risk MDS. Proc Natl Acad Sci U S A. 2009 Sep 29;106(39):16811-6.
77. Follo MY, Mongiorgi S, Finelli C, Clissa C, Ramazzotti G, Fiume R, Manzoli L, Martelli AM, Cocco L. Nuclear inositide signaling in myelodysplastic syndromes. J Cell Biochem. 2010 Apr 15;109(6):1065-71.